Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CELF4 | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-14 |
mRNA | SLIT3 | CCLE | pan-cancer | AAC | -0.27 | 4e-06 |
mRNA | CXCR4 | GDSC1000 | pan-cancer | AAC | -0.27 | 2e-10 |
mRNA | ZNF610 | CCLE | pan-cancer | AAC | -0.27 | 1e-08 |
mRNA | FAM184A | GDSC1000 | pan-cancer | AAC | -0.27 | 5e-14 |
mRNA | CFL2 | CCLE | pan-cancer | AAC | -0.27 | 6e-06 |
mRNA | SBK1 | GDSC1000 | pan-cancer | AAC | -0.28 | 4e-14 |
mRNA | ELAVL3 | GDSC1000 | pan-cancer | AAC | -0.28 | 3e-13 |
mRNA | TMEM170B | GDSC1000 | pan-cancer | AAC | -0.28 | 1e-15 |
mRNA | TAGLN3 | GDSC1000 | pan-cancer | AAC | -0.28 | 1e-15 |